• Thumbnail for Polycythemia vera
    In oncology, polycythemia vera (PV) is an uncommon myeloproliferative neoplasm in which the bone marrow makes too many red blood cells. The majority of...
    24 KB (2,683 words) - 10:59, 5 June 2024
  • Thumbnail for Polycythemia
    Treatment for polycythemia varies, and typically involves treating its underlying cause. Treatment of primary polycythemia (see polycythemia vera) could involve...
    29 KB (3,296 words) - 18:15, 8 June 2024
  • Thumbnail for Myeloproliferative neoplasm
    Chronic myeloid leukemia (CML) Chronic neutrophilic leukemia (CNL) Polycythemia vera (PV) Primary myelofibrosis (PMF) PMF, prefibrotic stage PMF, overt...
    16 KB (1,524 words) - 20:11, 12 February 2024
  • sold under the brand name Besremi, is a medication used to treat polycythemia vera. It is an interferon. It is given by injection. The most common side...
    11 KB (781 words) - 21:51, 10 November 2023
  • are observed in other myeloproliferative neoplasms, specifically polycythemia vera and essential thrombocythemia. The JAK2 protein is mutated giving...
    27 KB (2,954 words) - 00:11, 19 May 2024
  • Thumbnail for Ruxolitinib
    type of myeloproliferative neoplasm that affects the bone marrow; polycythemia vera, when there has been an inadequate response to or intolerance of hydroxyurea;...
    26 KB (2,090 words) - 02:10, 2 April 2024
  • Thumbnail for Bloodletting
    drawing of a unit of blood in specific cases like hemochromatosis, polycythemia vera, porphyria cutanea tarda, etc., to reduce the number of red blood...
    40 KB (4,374 words) - 02:53, 5 June 2024
  • and its vasodilatory effects. It can also be associated with lupus, polycythemia vera and homocystinuria. Malar flush is a plum-red discolouration of the...
    2 KB (184 words) - 23:41, 25 November 2021
  • Thumbnail for Fedratinib
    fedratinib in patients with high- or intermediate-risk primary or post–polycythemia vera/essential thrombocythemia myelofibrosis have been published in 2011...
    10 KB (690 words) - 07:17, 14 March 2024
  • Thumbnail for Hydroxycarbamide
    disease, essential thrombocythemia, chronic myelogenous leukemia, polycythemia vera, and cervical cancer. In sickle-cell disease it increases fetal hemoglobin...
    20 KB (1,806 words) - 04:05, 18 May 2024